Strategic partnerships WARF acts as the technology transfer arm for UW–Madison with a broad portfolio of over 2,000 licensed technologies across pharma, agriculture, IT, clean tech, and medical devices, presenting multiple licensing and co-development opportunities for global corporates and startups seeking university-originated innovations.

Investment and growth Recent funding activity and leadership hires indicate an active expansion in WARF Therapeutics and venture investments, suggesting opportunities for pharma and biotech partners to engage in early access, translational programs, or co-investment with WARF ventures and related funds.

Innovator network With a robust ecosystem around UW–Madison discoveries, WARF’s collaborations, awards, and ongoing research funding to UW projects create open doors for collaboration and sponsored research, licensing discussions, and strategic alliances with corporates seeking university-driven innovation pipelines.

Market-ready opportunities A diversified technology catalog spanning pharmaceuticals, agriculture, clean tech, and medical devices enables cross-sector licensing deals, joint ventures, or exclusive rights deals tailored to a company’s portfolio and go-to-market strategy.

Public and academic alignment WARF maintains visibility through awards, board leadership, and active communications, which can be leveraged for branding, thought leadership partnerships, and co-sponsored innovation events to accelerate deal flow and establish WARF as a preferred innovation partner.